EU Pharma Slams ICH Proposal For Selective Adoption Of Quality Guideline
An unprecedented proposal by the International Council for Harmonisation that would let member states selectively adopt certain parts of one of its quality guidelines has drawn criticism from EU pharmaceutical industry associations.
You may also be interested in...
EU authorities say the new tools and concepts needed for implementing the new international guideline on post-approval changes (ICH Q12) will be considered when the EU framework is reviewed.
Concerns about potential regional variation and ambiguous applicability subside with final revision of lifecycle management guideline; training preparations begin.
An international guideline on managing post approval changes to drugs, which was initially criticized because of its incompatibility with legal frameworks in certain ICH regions such as the EU, has been finalized.